TREATMENT READING
Plasma Cell Neoplasms (Including Multiple Myeloma)
Choose a source section by treatment, subtype or setting. Patient and professional reading are labelled separately.
Selected text from the National Cancer Institute, with original links and dates. This Triangle reading page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
28 studies cited in this topic · see design and results →
Explore 39 related disease and treatment settings → · Source-derived catalogue; clinical review pending.
Certain factors affect prognosis (chance of recovery) and treatment options.
Plasma cell neoplasms may not respond to treatment or may come back after treatment.
Treatment Option Overview
Key Points
There are different types of treatment for patients with plasma cell neoplasms.
The following types of treatment are used:
Chemotherapy
Other drug therapy
Targeted therapy
High-dose chemotherapy with stem cell transplant
Immunotherapy
Radiation therapy
Surgery
Watchful waiting
New types of treatment are being tested in clinical trials.
New combinations of therapies
Treatment for plasma cell neoplasms may cause side effects.
Supportive care is given to lessen the problems caused by the disease or its treatment.
Patients may want to think about taking part in a clinical trial.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Follow-up tests may be needed.
Treatment of Monoclonal Gammopathy of Undetermined Significance
Treatment of Isolated Plasmacytoma of Bone
Treatment of Extramedullary Plasmacytoma
Treatment of Multiple Myeloma
Treatment of Relapsed or Refractory Multiple Myeloma
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle